Renoprotection
Showing 1 - 25 of 43
Acute Kidney Injury, Cardiac Surgery, Sodium-Glucose Transporter 2 Inhibitor Trial in Netherlands (Dapagliflozin 10 MG Oral
Not yet recruiting
- Acute Kidney Injury
- +2 more
- Dapagliflozin 10 MG Oral Tablet [Farxiga]
- Placebo
-
Amsterdam, Netherlands
- +5 more
Oct 18, 2022
Diabetic Nephropathy Trial in Phoenix (Losartan, Placebo)
Type 2 Diabetes, Diabetic Kidney Disease, Diabetic Nephropathy Trial in Amsterdam (Ertugliflozin 15 mg)
Recruiting
- Type 2 Diabetes Mellitus
- +6 more
- Ertugliflozin 15 mg
-
Amsterdam, NetherlandsVU University Medical Center
Mar 30, 2021
Type 2 Diabetes, Nephropathy Trial (MK0954, losartan / Duration of Treatment: mean 3.4 years, Placebo / Duration of Treatment:
Completed
- Type 2 Diabetes
- Nephropathy
- MK0954, losartan / Duration of Treatment: mean 3.4 years
- Placebo / Duration of Treatment: mean 3.4 years
- (no location specified)
Feb 7, 2022
Myocardial Infarction Trial in Shibin Al Kawm (Dapagliflozin 10mg Tab, Placebo)
Recruiting
- Myocardial Infarction
- Dapagliflozin 10mg Tab
- Placebo
-
Shibīn Al Kawm, Menofia, EgyptMohammad Soliman
Aug 18, 2023
Chronic Kidney Diseases Trial in Belgium (Metformin Hydrochloride, Placebo Oral Tablet)
Recruiting
- Chronic Kidney Diseases
- Metformin Hydrochloride
- Placebo Oral Tablet
-
Roeselare, West-Vlaanderen, Belgium
- +18 more
Jan 19, 2021
Acute Kidney Injury Trial in Karachi (Dexmedetomidine, Normal Saline)
Completed
- Acute Kidney Injury
- Dexmedetomidine
- Normal Saline
-
Karachi, Sindh, PakistanNICVD Karachi
May 11, 2022
Severe Malaria, Malaria,Falciparum, Acute Kidney Injury Trial in Kinshasa (Paracetamol, Mechanical antipyresis)
Recruiting
- Severe Malaria
- +3 more
- Paracetamol
- Mechanical antipyresis
-
Kinshasa, Congo, Congo, The Democratic Republic of theThe Kinshasa Medical Oxford Research Unit (KIMORU)
Feb 17, 2022
Type2 Diabetes Trial in Amsterdam (EMPA/LINA 10/5 mg QD (n=22), LINA/EMPA 5/10 mg QD (N=22), Gliclazide 30 mg QD/BID (N=22))
Active, not recruiting
- Type2 Diabetes
- EMPA/LINA 10/5 mg QD (n=22)
- +2 more
-
Amsterdam, Noord-Holland, NetherlandsVU University Medical Center
Jan 13, 2022
Type 2 Diabetes, Diabetic Kidney Disease Trial in Changsha (Jinshuibao Capsule)
Active, not recruiting
- Type 2 Diabetes Mellitus
- Diabetic Kidney Disease
- Jinshuibao Capsule
-
Changsha, Hunan, ChinaThe Second Xiangya Hospital of Central South University
Dec 7, 2020
Diabetic Nephropathies Trial in Cairo (SGLT2 inhibitor, ACE inhibitor)
Unknown status
- Diabetic Nephropathies
- SGLT2 inhibitor
- ACE inhibitor
-
Cairo, EgyptAin Shams University Hospitals
Apr 18, 2020
Diabetes Type 2 Trial in Doha (Metformin, Gliclazide, Sitagliptin)
Active, not recruiting
- Diabetes Mellitus Type 2
- Metformin
- +6 more
-
Doha, QatarHamad Medical Corporation
Apr 27, 2022
COVID-19 Trial in Kermanshah (Deferoxamine)
Unknown status
- COVID-19
-
Kermanshah, Iran, Islamic Republic ofRegenerative Medicine Research Center, Kermanshah University of
Apr 30, 2020
Depressive Disorder, Major Trial (Dexmedetomidine Injection [Precedex], Normal saline)
Not yet recruiting
- Depressive Disorder, Major
- Dexmedetomidine Injection [Precedex]
- Normal saline
- (no location specified)
Dec 9, 2020
s of Kibow Biotics® in Chronic Kidney Failure
Completed
- Chronic Kidney Failure
-
Brooklyn, New York
- +1 more
Aug 16, 2019
Kibow Biotics in Chronic Kidney Failure Patients on Dialysis
Completed
- Chronic Kidney Disease
- Kibow Biotics
-
Brooklyn, New YorkParkside Dialysis Clinic at Downstate Medical Center
Aug 16, 2019
Observational Study of Kibow Biotics in Dialysis Patients
Completed
- Chronic Kidney Failure
- Kibow Biotics
-
Philadelphia, PennsylvaniaThomas Jefferson University
Aug 16, 2019
Diabetes, Type 2, Diabetic Nephropathies Trial in Amsterdam (Dapagliflozin 10mg QD, Gliclazide 30mg QD)
Completed
- Diabetes Mellitus, Type 2
- Diabetic Nephropathies
- Dapagliflozin 10mg QD
- Gliclazide 30mg QD
-
Amsterdam, Noord-Holland, NetherlandsVU University Medical Center
Jul 6, 2020
Type 2 Diabetes, Diabetic Nephropathy Trial in Xiamen (SGLT2 Inhibition)
Unknown status
- Type 2 Diabetes
- Diabetic Nephropathy
- SGLT2 Inhibition
-
Xiamen, Fujian, ChinaZhongshan Hospital Xiamen University
Oct 16, 2019
Vascular Calcification in Diabetic Nephropathy in Diabetic
Unknown status
- Diabetic Nephropathies
- Vascular Calcification
- Osteopontin (OPN)
-
Asyūţ, EgyptAssiut University
Jan 26, 2019
Contrast-induced Nephropathy Trial in Cali (Ischemic preconditioning, Endovenous normal saline)
Withdrawn
- Contrast-induced Nephropathy
- Ischemic preconditioning
- Endovenous normal saline
-
Cali, Valle Del Cauca, ColombiaGrupo Nefrología Fundación Valle del Lili
Oct 9, 2018
Chronic Renal Failure Trial in Taipei (ARB, Pentoxifylline, Placebo (for Pentoxifylline))
Unknown status
- Chronic Renal Failure
- ARB
- +2 more
-
Taipei, TaiwanNational Taiwan University Hospital
Oct 13, 2016
Autosomal Dominant Polycystic Kidney Disease Trial in Italy (Octreotide-LAR, Saline solution.)
Completed
- Autosomal Dominant Polycystic Kidney Disease
- Octreotide-LAR
- Saline solution.
-
Agrigento, AG, Italy
- +5 more
Jan 9, 2018
Pentoxifylline, Acute Kidney Injury Trial (Pentoxifylline 400Mg Tablet)
Unknown status
- Pentoxifylline
- Acute Kidney Injury
- Pentoxifylline 400Mg Tablet
- (no location specified)
Apr 24, 2017